(Q34067697)

30 July 2017

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group (English)

1 reference

30 July 2017

1 reference

Kaufman KD

1

1 reference

30 July 2017

Olsen EA

2

1 reference

30 July 2017

Whiting D

3

1 reference

30 July 2017

Savin R

4

1 reference

30 July 2017

DeVillez R

5

1 reference

30 July 2017

Bergfeld W

6

1 reference

30 July 2017

Price VH

7

1 reference

30 July 2017

Van Neste D

8

1 reference

30 July 2017

Roberts JL

9

1 reference

30 July 2017

Hordinsky M

10

1 reference

30 July 2017

Shapiro J

11

1 reference

30 July 2017

Binkowitz B

12

1 reference

30 July 2017

Gormley GJ

13

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

Journal of the American Academy of Dermatology

30 July 2017

1 reference

30 July 2017

39

1 reference

30 July 2017

4 Pt 1

1 reference

30 July 2017

578-589

1 reference

Male hormone stimulation is prerequisite and an incitant in common baldness

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Patterned loss of hair in man; types and incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Steroid 5 alpha-reductase: two genes/two enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Photographic documentation of hair growth in androgenetic alopecia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Procedures for comparing samples with multiple endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

The analysis of multiple endpoints in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

The effect of finasteride on prostate specific antigen: review of available data

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride. The Finasteride PSA Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970007-6

7 January 2021

10.1016/S0190-9622(98)70007-6

Identifiers

DOI

1 reference

30 July 2017

1 reference